New evidence on atenolol in hypertension
This article has no abstract so we have provided the first paragraph of the full text.
A new systematic review by Carlberg and colleagues has revealed that atenolol, one of the most common 
-blockers, might not be appropriate as a first-line treatment for hypertension.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Chemical biology Dressed-up proteinsNature News and Views (26 Apr 2007)
Biogeochemistry Iron findingsNature News and Views (26 Apr 2007)
Mal-function of TLRs by SOCSNature Immunology News and Views (01 Feb 2006)
Mathematical physics Added dimensions to grain growthNature News and Views (26 Apr 2007)
See all 5 matches for News And Views